Idera Pharma (IDRA) Posts Narrower than Expected Q4 Loss

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q4 loss of $0.22, $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $3.26 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• KULR Technology Group (KULR) Misses Q2 EPS by 39c
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c